MONAS
FINANCIAL
Home
About
Research
Data
Pricing
Team
News
Analysis
Press
Contact
Legal
← News
// Related Deep Analysis
Merck Reports Phase 2b/3 Trial Results for Investigational Diabetes Eye Drug
Read the full analysis →
Merck Says Investigational Diabetes-Related Blindness Drug at Par With Roche’s Medicine
News
MRK
Sep 24
AI-curated analysis for informational purposes only — not investment advice.
Merck Says Investigational Diabetes-Related Blindness Drug at Par With Roche’s Medicine
Read the full story at benzinga.com →